Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients

Press release

Automatable  and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The assay adds to the Company’s broad product portfolio for COVID-19 diagnostics and supports the molecular PCR tests to aid in diagnosing acute SARS-CoV-2 infections.

Read complete press release here.

Leave a Comment

Your email address will not be published. Required fields are marked *

captcha

Scroll to Top